Skip to main content
Log in

Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Two IgE-producing hybridomas were established from spleen cells of Balb/c mice, which had been immunized with mouse mammary tumor virus (MMTV). These IgE monoclonal antibodies (mAbs) reacted specifically with the major envelope glycoprotein (gp36) of MMTV, as established by the immunoblot assay and by passive cutaneous anaphylaxis. The effect of the IgE mAbs (produced by clone A8) on the growth of the MMTV-secreting mammary adenocarcinoma H2712 was investigated in syngeneic C3H/HeJ mice. The mice were inoculated s.c. with either 105 (≈100 × LD50) or 106 (≈1000 × LD50) tumor cells and received repeated i.p. injections of 25 µg anti-gp36 IgE mAbs at 4-day intervals for 8 weeks. This treatment prevented the development of subcutaneous tumors in 50% of the animals. Similar protection was observed when the tumor cells (105/animal) were injected i.p. 4 days prior to the beginning of the i.p. treatment consisting of injections of 25 µg mAbs at 4-day intervals for 6 weeks. However, these mAbs did not protect C3H/HeJ mice against the MMTV-negative MA16/c carcinoma cells. Hence, these results support the view that IgE-mediated cytotoxic mechanisms may play an immunologically specific antitumor surveillance role and that laboratory-induced antitumor IgE mAbs have the potential of specific therapeutic agents for in vivo destruction of tumor cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Allegra J, Lipton A, Harvey H, Luderer J, Brenner D, Mortel R, Demers L, Gillin M, White D, Trautlein J (1976) Decreased prevalence of immediate hypersensitivity (atopy) in a cancer population. Cancer Res 36: 3225

    PubMed  Google Scholar 

  2. Arbesman CE, Wypych JI, Reisman RE (1973) Serum IgE in human diseases. In: Mechanisms in allergy, reagin-mediated hypersensitivity. Dekker, New York, p 163

    Google Scholar 

  3. Augustin R, Chandradasa KD (1971) IgE levels and allergic skin reactions in cancer and non-cancer patients. Int Arch Allergy Appl Immunol 41: 141

    PubMed  Google Scholar 

  4. Bartholomaeus WM, Keast D (1972) Reaginic antibody to tumor and alloantigens in mice. Nature 239: 206

    Google Scholar 

  5. Berczi I, Holford-Strevens V, Warsi ZH, McMorris LS, Thorlakson RH, Thorlakson TH, Sehon AH (1983) Tumor-reactive IgE antibodies in plasma of patients with gastrointestinal carcinomas. Cancer Immunol Immunother 14: 180

    PubMed  Google Scholar 

  6. Black MM, Leis HP (1971) Cellular responses to autologous breast cancer tissue. Correlation with stage and lymphoreticuloendothelial reactive. Cancer 28: 263

    PubMed  Google Scholar 

  7. Black MM, Leis HP Jr (1973) Cellular responses to autologous breast cancer tissue. Sequential observations. Cancer 32: 384

    PubMed  Google Scholar 

  8. Broom BC, Alexander P (1975) Rat tumor allografts evoke anaphylactic antibody responses. Immunology 28: 1033

    PubMed  Google Scholar 

  9. Bross IDJ, Natarajan N (1972) Leukemia from low-level radiation. Identification of susceptible children. N Engl J Med 287: 107

    PubMed  Google Scholar 

  10. Burtin C, Scheinmann P, Salomon JC, Lespinats G, Frayssinet C, Lebel B, Canu P (1981) Increased tissue histamine in tumour-bearing mice and rats. Br J Cancer 43: 684

    PubMed  Google Scholar 

  11. Burtin C, Scheinmann P, Salomon JC, Lespinats G, Loisillier F, Canu P (1981) The influence of intraperitoneal injections of histmaines on tumor growth in fibrosarcoma-bearing mice. Cancer Lett 12: 195

    PubMed  Google Scholar 

  12. Burtin C, Scheinmann P, Salomon JC, Lespinats G, Canu P (1982) Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma bearing mice: influence of H1 and H2 histamine receptors. Br J Cancer 45: 54

    PubMed  Google Scholar 

  13. Burtin C, Noirot C, Paupe J, Scheinmann P (1983) Decreased blood histamine levels in patients with solid malignant tumours. Br J Cancer 47: 367

    PubMed  Google Scholar 

  14. Burtin C, Ponvert C, Fray A, Scheinmann P, Lespinats G, Loridon B, Canu P, Paupe J (1985) Inverse correlation between tumor incidence and tissue histamine levels in W/W/, W/+ and +/+ mice. JNCI 74: 671

    PubMed  Google Scholar 

  15. Capron M (1988) Eosinophils in diseases: receptors and mediators: In: Progress in allergy and clinical immunology (Proc. 13th Int Cong Allergy Clin Immunol). Hogrefe & Huber, Toronto, p 6

    Google Scholar 

  16. Chaudhary VK (1990) A rapid method of cloning functional variable-region antibody genes inE. coli as single chain immunotoxins. Second Int Symp Immunotoxins, Lake Buena Vista, Fla.

    Google Scholar 

  17. Conrad DH (1989) Low affinity IgE (FcE R II) receptors. Clin Rev Allergy 7: 165

    PubMed  Google Scholar 

  18. Daams JH, Hageman P, Calafat J, Bentvelzen P (1973) Antigenic structure of murine mammary tumour viruses. Eur J Cancer 9: 567

    PubMed  Google Scholar 

  19. Fisherman EW (1960) Does the allergic diathesis influence malignancy? J Allergy 31: 74

    PubMed  Google Scholar 

  20. Galfre G, Milstein C (1981) Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 73: 1

    PubMed  Google Scholar 

  21. Gershoni JM (1987) Protein blotting: a manual. Methods Biochem Anal 33: 1

    Google Scholar 

  22. Grace JT, Kondo T (1958) Investigations of host resistance in cancer patients. Ann Surg 148: 633

    PubMed  Google Scholar 

  23. Haba S, Ovary Z, Nisonoff A (1985) Clearance of IgE from serum of normal and hybridoma-bearing mice. J Immunol 134: 3291

    PubMed  Google Scholar 

  24. Hirano T, Hom C, Ovary Z (1983) Half life of murine IgE antibodies in the mouse. Int Arch Allergy Appl Immunol 71: 182

    PubMed  Google Scholar 

  25. Hoogenraad N, Helman T, Hoogenraad J (1983) The effect of preinjection of mice with pristane on ascites tumour formation and monoclonal antibody production. J Immunol Methods 61: 317

    PubMed  Google Scholar 

  26. Jacobs D, Landon J, Houri M, Merrett TG (1972) Circulating levels of immunoglobulin E in patients with cancer. Lancet II: 1059

    Google Scholar 

  27. Keller R, Ogilvie BM, Simpson E (1971) Tumour growth in nemotode-infected animals. Lancet I: 678

    Google Scholar 

  28. Kelly KA, Lang GM, Bundesen PG, Holford-Strevens V, Bottcher I, Sehon AH (1980) The development of a radioallergosorbent test (RAST) for murine IgE antibodies. J Immunol Methods 39: 317

    PubMed  Google Scholar 

  29. Kenten JH, Molgaard HV, Houghton M, Derbyshire, RB, Viney J, Bell LO, Gould H (1982) Cloning and sequence determination of the gene for the human immunoglobulin ε chain expressed in a myeloma cell line. Proc Natl Acad Sci USA 79: 6661

    PubMed  Google Scholar 

  30. Kenten J, Helm B, Ishizaka T, Cattini P, Gould H (1984) Properties of a human immunoglobulin ε-chain fragment synthesized inEscherichia coli. Proc Natl Acad Sci USA 81: 2955

    PubMed  Google Scholar 

  31. Kernan NA, Byers V, Scannon PJ, Mischak RP, Brochstein MD, Flomenberg N, Dupont B, O'Reilly RJ (1988) Treatment of steroidresistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin. J Am Med Assoc 259: 3154

    Google Scholar 

  32. Lee N, Zhang SQ, Testa D (1988) A rapid multicolor Western blot. J Immunol Methods 106: 27

    PubMed  Google Scholar 

  33. Likhite VV (1974) The delayed and lasting rejection of mammary adenocarcinoma cell tumors in DBA/2 mice with use of killedBordetella pertussis. Cancer Res 34: 1027

    PubMed  Google Scholar 

  34. Liu F-T, Bohn JW, Ferry EL, Yamamoto H, Molinardo CA, Sherman LA, Klinman NR, Katz DH (1980) Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol 124: 2728

    PubMed  Google Scholar 

  35. Logan J, Saker DN (1953) The incidence of allergic disorders in cancer. NZ Med J 52: 210

    Google Scholar 

  36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265

    PubMed  Google Scholar 

  37. Lynch NR, Salomon JC (1977) Passive local anaphylaxis: demonstration of antitumor activity and complementation of intratumor BCG. JNCI 58: 1093

    PubMed  Google Scholar 

  38. Maiti PK, Lang GM, Sehon AH (1988) Tolerogenic conjugates of xenogeneic monoclonal antibodies with monomethoxypolyethylene glycol: I. Induction of long-lasting tolerance to xenogeneic monoclonal antibodies. Int J Cancer [Suppl] 3: 17

    Google Scholar 

  39. McKay WD (1966) The incidence of allergic disorders and cancer. Br J Cancer 20: 434

    PubMed  Google Scholar 

  40. Meers PD (1973) Allergy and cancer. Lancet I: 884

    Google Scholar 

  41. Metzger H (1988) Molecular aspects of receptors and binding factors for IgE. Adv Immunol 43: 277

    PubMed  Google Scholar 

  42. Reichmann L, Clark M, Waldmann H, Winter G (1988) Reshaping human antibodies for therapy. Nature 332: 323

    PubMed  Google Scholar 

  43. Scheinmann P, Lebel B, Lynch NR, Salomon JC, Paupe JR, Burtin C (1979) Histamine levels in blood and other tissues of male and female C3H mice: II. Mice carrying a 3-methyl-cholanthrene-induced tumor. Agents Action 9: 95

    Google Scholar 

  44. Sehon AH (1982) Suppression of IgE antibody responses with tolerogenic conjugates of allergens and haptens. Prog Allergy 32: 161

    PubMed  Google Scholar 

  45. Shoenfeld Y, Amnon H, Tal R, Smorodinsky NI, Lavie G, Mor C, Schteren S, Mammon Z, Pinkhas J, Keydar T (1987) Human monoclonal antibodies derived from lymph nodes of a patient with breast carcinoma react with MuMTV polypeptides. Cancer 59: 43

    PubMed  Google Scholar 

  46. Stage DE, Mannik M (1974) Covalent binding of molecules to CNBr-activated agarose: parameters relevant to the activation and coupling reactons. Biochem Biophys Res Commun 343: 382

    Google Scholar 

  47. Sweeney WT, Seibel HR (1973) Histamine release from peritoneal mast cells of tumor susceptible rats following periods of tumor growth and sensitization with tumor antigen andB. pertussis. Int Arch Allergy 45: 789

    PubMed  Google Scholar 

  48. Tsang VCW, Peralta JM, Simons AR (1983) Enzyme-linked immunoelectro-transfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol 92: 377

    PubMed  Google Scholar 

  49. Waldmann TA, Bull JM, Bruce RM, Broder S, Jost MC, Balestra ST, Suer ME (1974) Serum immunoglobulin E levels in patients with neoplastic disease. J Immunol 113: 379

    PubMed  Google Scholar 

  50. Weatherly NF (1970) Increased survival of Swiss mice given sublethal injections ofTrichinella spiralis. J Parasitol 56: 748

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nagy, E., Berczi, I. & Sehon, A.H. Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus. Cancer Immunol Immunother 34, 63–69 (1991). https://doi.org/10.1007/BF01741326

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01741326

Key words

Navigation